Reaction Details Report a problem with these data
Target
Protein Nef
Ligand
BDBM288107
Substrate
n/a
Meas. Tech.
Measurement of Antiviral (HIV-1) Activity
Temperature
298.15±n/a K
EC50
2.10±n/a nM
Comments
extracted
Citation
 Miyazaki, S; Isoshima, H; Oshita, K; Kawashita, S; Nagahashi, N; Terashita, M Substituted spiropyrido[1,2-a]pyrazine derivative and medicinal use thereof as HIV integrase inhibitor US Patent  US10087178 Publication Date 10/2/2018 
Target
Name:
Protein Nef
Synonyms:
3ORF | F-protein | HIV-1 Nef | NEF_HV1BR | Negative factor | Protein Nef | nef
Type:
C-terminal core protein
Mol. Mass.:
23340.47
Organism:
Human immunodeficiency virus type 1 (isolate BRU/LAI group M subtype B)
Description:
P03406
Residue:
206
Sequence:
MGGKWSKSSVVGWPTVRERMRRAEPAADGVGAASRDLEKHGAITSSNTAATNAACAWLEAQEEEEVGFPVTPQVPLRPMTYKAAVDLSHFLKEKGGLEGLIHSQRRQDILDLWIYHTQGYFPDWQNYTPGPGVRYPLTFGWCYKLVPVEPDKVEEANKGENTSLLHPVSLHGMDDPEREVLEWRFDSRLAFHHVARELHPEYFKNC
  
Inhibitor
Name:
BDBM288107
Synonyms:
Production of Monopotassium 7′-(3-chloro-2-fluorobenzylcarbamoyl)-cis-3-methoxy-2′-methyl-1′,8′-dioxo-1′,2′,3′,8′-tetrahydrospiro[cyclobutane-1,4′-pyrido[1,2-a]pyrazin]-9′-olate | US10087178, Example 25
Type:
Small organic molecule
Emp. Form.:
C21H20ClFKN3O5
Mol. Mass.:
487.95
SMILES:
CO[C@H]1C[C@@]2(C1)CN(C)C(=O)c1c(O[K])c(=O)c(cn21)C(=O)NCc1cccc(Cl)c1F |r,wU:4.4,wD:2.1,(8.72,-11.16,;7.39,-10.39,;7.39,-8.85,;8.48,-7.76,;7.39,-6.67,;6.3,-7.76,;8.72,-5.9,;8.72,-4.36,;10.06,-3.59,;7.39,-3.59,;7.39,-2.05,;6.05,-4.36,;4.72,-3.59,;4.72,-2.05,;3.39,-1.28,;3.39,-4.36,;2.05,-3.59,;3.39,-5.9,;4.72,-6.67,;6.05,-5.9,;2.05,-6.67,;2.05,-8.21,;.72,-5.9,;-.61,-6.67,;-1.95,-5.9,;-1.95,-4.36,;-3.28,-3.59,;-4.61,-4.36,;-4.61,-5.9,;-5.95,-6.67,;-3.28,-6.67,;-3.28,-8.21,)|
Structure:
Search PDB for entries with ligand similarity: